查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1542526

全球 AAV 合約開發和製造組織市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global AAV Contract Development And Manufacturing Organizations Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

全球 AAV 合約開發和製造組織市場需求預計將從 2023 年的 6.8398 億美元達到近 29.9921 億美元的市場規模，2024 年至 2032 年研究期間的複合年成長率為 17.85%。

AAV（腺相關病毒）合約開發和製造組織 (CDMO) 是專門從事基於 AAV 的基因療法的開發、製造和測試的公司。 AAV 是一種小型非致病性病毒，通常用作基因治療中基因傳遞的載體。 AAV CDMO 與客戶合作，針對特定治療應用設計和最佳化 AAV 載體。他們還提供 AAV 載體的生產服務，包括細胞系的開發、載體生產過程的最佳化以及最終產品的純化和表徵。此外，AAV CDMO 對 AAV 載體進行嚴格的測試，以確保安全性和有效性，包括效力、純度、無菌和身份測試。

市場動態

隨著越來越多的基因治療產品被批准用於臨床，基因治療市場正在迅速擴大。 AAV 載體是基因治療遞送的熱門選擇，對基因治療的需求不斷成長正在推動 AAV CDMO 市場的成長。 AAV 載體技術的進步改進了載體生產流程、提高了轉導效率並減少了免疫反應。這些進步使 AAV 載體對基因療法應用更具吸引力，並增加了對 AAV CDMO 服務的需求。近年來，基因治療研究的資金供應大幅增加，政府機構、私人投資者和非營利組織都為基因治療市場的成長做出了貢獻。這筆資金正在推動新基因療法的開發，進而增加對 AAV CDMO 服務的需求。 FDA 等監管機構已表示支持基因療法的開發，並實施了基因療法產品的快速批准途徑。這種監管支持有助於推動基因治療市場的成長，包括 AAV CDMO 市場。許多生技和製藥公司選擇將基因治療製造外包給專門的 CDMO，而不是投資昂貴的內部設施。這一趨勢導致對 AAV CDMO 服務的需求不斷增加，因為這些公司正在尋找經驗豐富的合作夥伴來幫助他們開發和製造基因療法產品。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對 AAV 合約開發和製造組織全球市場的每個細分市場進行包容性評估。 AAV 合約開發和製造組織行業的成長和趨勢為本研究提供了整體方法。

市場區隔

AAV 合約開發和製造組織市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按工作流程

  • 上游處理（向量放大和擴展、向量恢復和收穫）
  • 下游加工（純化、填充完成）

依文化類型

  • 依附文化
  • 懸浮文化

按申請

  • 細胞與基因療法開發
  • 疫苗開發
  • 生物製藥與藥物發現
  • 生物醫學研究

按最終用戶

  • 製藥及生物製藥公司
  • 學術及研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的 AAV 合約開發和製造組織市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 AAV 合約開發和製造組織市場的主要參與者包括 Thermo Fischer Scientific Inc.、Creative Biogene、Catalent Inc.、Charles River Laboratories International Inc.、Danaher (Aldevron)、Forge Biologics、Genezen、ViroCell Biologics、Merck KGaA、Viralgen 、 Biovian Oy、Esco Lifesciences (Esco Aster Pte. Ltd.)、GenScript ProBio、Porton Advanced Solution Ltd、Ask Bio、Showa Denko、Takara Bio Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如作為關鍵的併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：AAV 合約開發與製造組織 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 依工作流程進行市場吸引力分析
    • 按文化類型進行的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球 AAV 合約開發與製造組織市場分析：按工作流程

  • 按工作流程概述
  • 歷史和預測數據
  • 按工作流程分析
  • 上游處理（向量放大和擴展、向量恢復和收穫）
  • 下游加工（純化、填充完成）

第 6 章：全球 AAV 合約開發與製造組織市場分析：按文化類型

  • 按文化類型概述
  • 歷史和預測數據
  • 按文化類型分析
  • 依附文化
  • 懸浮文化

第 7 章：全球 AAV 合約開發與製造組織市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 細胞與基因療法開發
  • 疫苗開發
  • 生物製藥與藥物發現
  • 生物醫學研究

第 8 章：全球 AAV 合約開發與製造組織市場分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 製藥及生物製藥公司
  • 學術及研究機構

第 9 章：全球 AAV 合約開發與製造組織市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：AAV 合約開發與製造組織公司的競爭格局

  • AAV 合約開發和製造組織市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Thermo Fischer Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Creative Biogene
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Catalent Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Charles River Laboratories International Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher (Aldevron)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Forge Biologics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Genezen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • ViroCell Biologics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Viralgen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Biovian Oy
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Esco Lifesciences (Esco Aster Pte. Ltd.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GenScript ProBio
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Porton Advanced Solution Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Ask Bio
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Showa Denko
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Takara Bio Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112110635

The global demand for AAV Contract Development And Manufacturing Organizations Market is presumed to reach the market size of nearly USD 2999.21 Million by 2032 from USD 683.98 Million in 2023 with a CAGR of 17.85% under the study period 2024 - 2032.

AAV (adeno-associated virus) Contract Development and Manufacturing Organizations (CDMOs) are companies that specialize in the development, manufacturing, and testing of AAV-based gene therapies. AAV is a small, non-pathogenic virus that is commonly used as a vector for gene delivery in gene therapy. AAV CDMOs work with clients to design and optimize AAV vectors for specific therapeutic applications. They also provide services for the production of AAV vectors, including the development of cell lines, optimization of vector production processes, and purification and characterization of the final product. In addition, AAV CDMOs conduct rigorous testing of the AAV vectors to ensure safety and efficacy, including tests for potency, purity, sterility, and identity.

MARKET DYNAMICS

The market for gene therapies is expanding rapidly as more gene therapy products are approved for clinical use. AAV vectors are a popular choice for gene therapy delivery, and the increasing demand for gene therapies is driving growth in the AAV CDMO market. Advances in AAV vector technology have led to improved vector production processes, increased transduction efficiency, and reduced immune responses. These advances have made AAV vectors more attractive for gene therapy applications and have increased the demand for AAV CDMO services. The availability of funding for gene therapy research has increased significantly in recent years, with government agencies, private investors, and non-profit organizations all contributing to the gene therapy market growth. This funding is driving the development of new gene therapies, which in turn is increasing demand for AAV CDMO services. Regulatory agencies such as the FDA have shown support for the development of gene therapies and have implemented expedited approval pathways for gene therapy products. This regulatory support is helping to drive growth in the gene therapy market, including the AAV CDMO market. Many biotech and pharma companies are choosing to outsource their gene therapy manufacturing to specialized CDMOs rather than investing in expensive in-house facilities. This trend is increasing demand for AAV CDMO services as these companies seek out experienced partners to help them develop and manufacture their gene therapy products.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of AAV Contract Development And Manufacturing Organizations. The growth and trends of AAV Contract Development And Manufacturing Organizations industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the AAV Contract Development And Manufacturing Organizations market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Workflow

  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting)
  • Downstream Processing (Purification, Fill Finish)

By Culture Type

  • Adherent Culture
  • Suspension Culture

By Application

  • Cell & Gene Therapy Development
  • Vaccine Development
  • Biopharmaceutical & Pharmaceutical Discovery
  • Biomedical Research

By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the AAV Contract Development And Manufacturing Organizations market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the AAV Contract Development And Manufacturing Organizations market include Thermo Fischer Scientific Inc., Creative Biogene, Catalent Inc., Charles River Laboratories International Inc., Danaher (Aldevron), Forge Biologics, Genezen, ViroCell Biologics, Merck KGaA, Viralgen, Biovian Oy, Esco Lifesciences (Esco Aster Pte. Ltd.), GenScript ProBio, Porton Advanced Solution Ltd, Ask Bio, Showa Denko, Takara Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Workflow
    • 3.7.2 Market Attractiveness Analysis By Culture Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY WORKFLOW

  • 5.1. Overview By Workflow
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Workflow
  • 5.4. Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Historic and Forecast Sales By Regions
  • 5.5. Downstream Processing (Purification, Fill Finish) Historic and Forecast Sales By Regions

6. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY CULTURE TYPE

  • 6.1. Overview By Culture Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Culture Type
  • 6.4. Adherent Culture Historic and Forecast Sales By Regions
  • 6.5. Suspension Culture Historic and Forecast Sales By Regions

7. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cell & Gene Therapy Development Historic and Forecast Sales By Regions
  • 7.5. Vaccine Development Historic and Forecast Sales By Regions
  • 7.6. Biopharmaceutical & Pharmaceutical Discovery Historic and Forecast Sales By Regions
  • 7.7. Biomedical Research Historic and Forecast Sales By Regions

8. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-User
  • 8.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 8.5. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS COMPANIES

  • 10.1. AAV Contract Development And Manufacturing Organizations Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF AAV CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fischer Scientific Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Creative Biogene
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Catalent Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Charles River Laboratories International Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Danaher (Aldevron)
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Forge Biologics
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Genezen
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. ViroCell Biologics
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Merck KGaA
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Viralgen
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Biovian Oy
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Esco Lifesciences (Esco Aster Pte. Ltd.)
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. GenScript ProBio
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Porton Advanced Solution Ltd
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Ask Bio
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Showa Denko
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments
  • 11.19. Takara Bio Inc
    • 11.19.1 Company Overview
    • 11.19.2 Company Revenue
    • 11.19.3 Products
    • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Workflow (USD MN)
  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales By Geography (USD MN)
  • Downstream Processing (Purification, Fill Finish) Market Sales By Geography (USD MN)
  • Analysis By Culture Type (USD MN)
  • Adherent Culture Market Sales By Geography (USD MN)
  • Suspension Culture Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cell & Gene Therapy Development Market Sales By Geography (USD MN)
  • Vaccine Development Market Sales By Geography (USD MN)
  • Biopharmaceutical & Pharmaceutical Discovery Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global AAV Contract Development And Manufacturing Organizations Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of AAV Contract Development And Manufacturing Organizations Report
  • Market Research Process
  • Market Research Methodology
  • Global AAV Contract Development And Manufacturing Organizations Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Culture Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Workflow (USD MN)
  • Upstream Processing (Vector Amplification & Expansion, Vector Recovery & Harvesting) Market Sales By Geography (USD MN)
  • Downstream Processing (Purification, Fill Finish) Market Sales By Geography (USD MN)
  • Global Market Analysis By Culture Type (USD MN)
  • Adherent Culture Market Sales By Geography (USD MN)
  • Suspension Culture Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cell & Gene Therapy Development Market Sales By Geography (USD MN)
  • Vaccine Development Market Sales By Geography (USD MN)
  • Biopharmaceutical & Pharmaceutical Discovery Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.